Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
about
Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell lineWhat Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal StudiesDetermination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.Interaction of Decay-Accelerating Factor with Coxsackievirus B3Interaction of Decay-Accelerating Factor with Echovirus 7Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in miceHuman Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor FunctionPathogenesis of Afa/Dr diffusely adhering Escherichia coli.A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells.Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.Characterization of a putative ancestor of coxsackievirus B5.Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulationCoxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.Attempts to prepare suitable complement regulatory molecules for clinical xenotransplantation.Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cellsCardiac gene activation analysis in mammalian non-myoblasic cells by Nkx2-5, Tbx5, Gata4 and MyocdCoxsackievirus B3 Directly Induced Th17 Cell Differentiation by Inhibiting Nup98 Expression in Patients with Acute Viral Myocarditis.Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditisAttenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.The management of myocarditis.The cell biology of receptor-mediated virus entry.Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts.Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.Novel role for decay-accelerating factor in coxsackievirus A21-mediated cell infectivity.Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis.MyocarditisMyocarditis
P2860
Q21284422-F62715EA-0371-45E2-8073-972A632A002AQ26738973-5DE75CA3-E01B-4092-8777-6034C7AD6BC0Q27639329-65A6418E-ED71-40BF-91C0-742BC1ACBF86Q27639359-F310B893-2D0A-418E-A4A7-547CD79EC942Q27647885-B9121E10-BC9A-40C2-BA74-D63D0C61A34EQ27664791-0BBF9804-B987-4DA8-81B0-3FD1B5A3AFE3Q28203874-7A4349A0-2FDA-41D6-A507-5682519FA545Q28217335-0A49DF6B-98EF-4D20-8AA8-7E010F7A9F0AQ33755215-0D372AD6-FC21-4AF8-8852-D09ED56DE5B8Q33877444-D3E2C283-2A36-4ED2-9923-156994865F2DQ34103142-786691DB-32B3-4045-ABBD-29EA4288BB43Q34120873-74E74404-1AD7-45F7-B233-326FED55CE0FQ34127130-0F9FAB77-C9E7-4B64-BD15-B2F009AB1E08Q34333784-2939E0BA-B5D0-4DD4-9B52-684E45B24C43Q34582615-F4D5C618-3049-487B-8600-0410AECCC8C8Q36318116-C8968435-3490-46DA-8DC0-F823C6010D25Q36354005-3C1B942B-339A-49CA-952F-118BBA84D25EQ37486647-3D46DAE5-67BE-47B2-AE48-9464A270B35EQ37596593-F0F129C2-A608-43BD-81D6-356E64AFF62CQ37683219-C73FE543-FB85-440A-BB0D-B76F1A1FA790Q37894482-1D66255C-B8A2-455A-AE3F-77AE802B6BD3Q37962258-F7EFD198-5197-4CD6-A0CD-ADEDB180496DQ39582322-13DD8FD7-F00D-4B9D-A43C-5786742A82E6Q39684666-400B897A-D6C8-46BE-8BC7-A89F31D7A7A1Q39738006-1F5F58CD-AF00-4013-8C47-F8132A154A92Q40278584-9520EFF4-4AC8-4AB8-BE50-AD2037FF9A29Q40468698-175DC1E3-4123-464C-8623-281584CCCE8AQ45732655-2AAC51F2-87D0-4767-9515-D946CAAC5B4BQ51839250-8DD5CD00-8678-4007-B6B5-E8721B5BB114Q55953402-E5B15139-D941-4EF6-A9D3-A663D5DBFA8DQ56933171-F90FE0E5-22AA-41C8-888F-CA848A81684F
P2860
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
@en
Cardiovirulent coxsackieviruses and the decay-accelerating factor
@nl
type
label
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
@en
Cardiovirulent coxsackieviruses and the decay-accelerating factor
@nl
prefLabel
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
@en
Cardiovirulent coxsackieviruses and the decay-accelerating factor
@nl
P2093
P356
P1433
P1476
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
@en
P2093
Martino TA
Richardson CD
P304
P356
10.1006/VIRO.1998.9122
P407
P577
1998-05-01T00:00:00Z